Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.54 |
| ▸ | MAPT | P10636 | 6/20 | 0.54 |
| ▸ | RECQL | P46063 | 5/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.54 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.54 |
| ▸ | POLB | P06746 | 4/20 | 0.54 |
| ▸ | GAA | P10253 | 4/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.54 |
| ▸ | CA12 | O43570 | 3/20 | 0.54 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.54 |
| ▸ | CA4 | P22748 | 3/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.54 |
| ▸ | CA7 | P43166 | 3/20 | 0.54 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | PKM | P14618 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15544677 | 0.82 | RECQL (0.55) | CYP3A4HSD17B10MAPTRECQLKDM4E | |
| SCHEMBL31237635 | 0.82 | RECQL (0.55) | CYP3A4HSD17B10MAPTRECQLKDM4E | |
| SCHEMBL28763278 | 0.81 | CYP1A2 (0.51) | CYP3A4HSD17B10MAPTRECQLKDM4E | |
| SCHEMBL6068882 | 0.71 | CYP3A4 (0.53) | CYP3A4HSD17B10MAPTRECQLKDM4E | |
| Eriodictyol SCHEMBL23686074 | 0.70 | CYP19A1 (1.00) | CYP3A4HSD17B10MAPTRECQLKDM4E | |
| Eriodictyol SCHEMBL29709569 | 0.70 | CYP19A1 (1.00) | CYP3A4HSD17B10MAPTRECQLKDM4E | |
| Eriodictyol SCHEMBL29382523 | 0.70 | CYP19A1 (1.00) | CYP3A4HSD17B10MAPTRECQLKDM4E | |
| Eriodictyol SCHEMBL19180 | 0.70 | CYP19A1 (1.00) | CYP3A4HSD17B10MAPTRECQLKDM4E | |
| Eriodictyol SCHEMBL30468822 | 0.70 | CYP19A1 (1.00) | CYP3A4HSD17B10MAPTRECQLKDM4E | |
| Eriodictyol SCHEMBL29603762 | 0.70 | CYP19A1 (1.00) | CYP3A4HSD17B10MAPTRECQLKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230233513-A1 | TAXIFOLIN FORMULATION COMPRISING THIAMINE | EVANIUM HEALTHCARE GMBH (DE) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230233513-A1 | TAXIFOLIN FORMULATION COMPRISING THIAMINE | SLC19A2, TTPA, FPGS | CYP3A4 1472/4885HSD17B10 2981/4885MAPT 722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.